Mediwound (M8W) Financial Statements
Mediwound Financial Overview
Mediwound's market cap is currently $153.23M. The company's EPS TTM is $-1.60; its P/E ratio is -8.31; Mediwound is scheduled to report earnings on November 12, 2026, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.96M | $ 20.22M | $ 18.69M | $ 26.50M | $ 23.76M |
| Gross Profit | $ 3.25M | $ 2.63M | $ 3.58M | $ 13.16M | $ 8.77M |
| Operating Income | $ -25.28M | $ -19.38M | $ -15.50M | $ -7.66M | $ -11.22M |
| EBITDA | $ -21.47M | $ -27.93M | $ -4.80M | $ -18.25M | $ -11.38M |
| Net Income | $ -23.88M | $ -30.22M | $ -6.72M | $ -19.60M | $ -13.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 53.14M | $ 43.16M | $ 41.54M | $ 33.90M | $ 11.05M |
| Total Assets | $ 86.25M | $ 73.50M | $ 66.46M | $ 50.02M | $ 19.74M |
| Total Debt | $ 8.15M | $ 6.93M | $ 6.35M | $ 846.00K | $ 1.39M |
| Net Debt | $ 3.35M | $ -2.22M | $ -5.52M | $ -33.05M | $ -9.65M |
| Total Liabilities | $ 42.62M | $ 42.34M | $ 34.86M | $ 39.10M | $ 24.33M |
| Stockholders' Equity | $ 43.63M | $ 31.15M | $ 31.59M | $ 10.91M | $ -4.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.04M | $ -19.90M | $ -16.93M | $ -12.44M | $ -9.40M |
| Operating Cash Flow | $ -14.53M | $ -13.62M | $ -10.46M | $ -11.88M | $ -8.92M |
| Investing Cash Flow | $ -19.54M | $ -8.40M | $ -34.32M | $ -481.00K | $ 3.55M |
| Financing Cash Flow | $ 29.62M | $ 19.39M | $ 22.92M | $ 35.76M | $ -1.05M |
Currency in USD